These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2874823)

  • 1. Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.
    Wilson JA; Johnston DA; Penston J; Wormsley KG
    Br J Clin Pharmacol; 1986 Jun; 21(6):685-9. PubMed ID: 2874823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man.
    Boyd EJ; Wormsley KG
    Eur J Clin Pharmacol; 1984; 26(4):443-7. PubMed ID: 6145595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory effects of CM57755. A new histamine H2 receptor antagonist.
    Wilson JA; Johnston D; Penston J; Wormsley KG
    Eur J Clin Pharmacol; 1986; 30(1):33-6. PubMed ID: 2872060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric secretion following single morning or twice daily oral administration of sufotidine to volunteers.
    Johnston DA; Wormsley KG
    Br J Clin Pharmacol; 1989 Oct; 28(4):403-7. PubMed ID: 2574050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats.
    Impicciatore M; Chiavarini M; Morini G; Barocelli E; Molina E; Plazzi PV
    Agents Actions; 1985 Sep; 16(6):496-500. PubMed ID: 2866688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man.
    Smith JL; Gamal MA; Chremos AN; Graham DY
    Dig Dis Sci; 1985 Apr; 30(4):308-12. PubMed ID: 2858363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.
    Ryan JR; Chremos AN; Vargas R; Mantell G; Johnson CL; McMahon FG
    Clin Pharmacol Ther; 1987 Aug; 42(2):225-31. PubMed ID: 2886245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid blockade by omeprazole or ICI 162846 in a chronic duodenal ulcer model.
    Gompertz RH; Man WK; Li SK; Spencer J; Baron JH; Michalowski AS
    Agents Actions; 1991 May; 33(1-2):161-3. PubMed ID: 1716826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric acid and pepsin secretion after single oral doses of mifentidine in healthy subjects.
    Lazzaroni M; Imbimbo BP; Sangaletti O; Bianchi Porro G
    Scand J Gastroenterol; 1988 Sep; 23(7):788-92. PubMed ID: 2906453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 75 mg HOE 760, a novel H2-receptor antagonist, on daytime peptone-stimulated and nocturnal gastric acid output in healthy volunteers.
    Hagenmüller F; Weber C; Hausmann S; Labs R; Malerczyk V; de Looze S; Classen M
    Scand J Gastroenterol; 1987 Jun; 22(5):609-14. PubMed ID: 2888185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cimetidine and oxmetidine on 24-h gastric acid and pepsin in patients.
    Gotthard R; Berstad A; Bodemar G; Norlander B; Walan A
    Scand J Gastroenterol; 1983 Sep; 18(6):809-17. PubMed ID: 6422538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
    de Gara CJ; Burget DW; Silletti C; Hunt RH
    Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
    Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
    Kovacs TO; Van Deventer GM; Maxwell V; Sytnik B; Walsh JH
    Scand J Gastroenterol Suppl; 1987; 136():41-6. PubMed ID: 2892254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
    Chiverton SG; Burget DW; Hunt RH
    Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid inhibitory characteristics of nizatidine in man: an overview.
    Parente F; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1994; 206():3-7. PubMed ID: 7863250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.